These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 34445596)

  • 1. Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation.
    Kim MJ; Kim HS; Lee S; Min KY; Choi WS; You JS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 3. HBP/O-GlcNAcylation Metabolic Axis Regulates Bone Resorption Outcome.
    Taira TM; Ramos-Junior ES; Melo PH; Costa-Silva CC; Alteen MG; Vocadlo DJ; Dias WB; Cunha FQ; Alves-Filho JC; Søe K; Fukada SY
    J Dent Res; 2023 Apr; 102(4):440-449. PubMed ID: 36749069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucosamine Suppresses Osteoclast Differentiation through the Modulation of Glycosylation Including O-GlcNAcylation.
    Takeuchi T; Sugimoto A; Imazato N; Tamura M; Nakatani S; Kobata K; Arata Y
    Biol Pharm Bull; 2017; 40(3):352-356. PubMed ID: 28250278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
    Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
    Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAcylation inhibition redirects the response of colon cancer cells to chemotherapy from senescence to apoptosis.
    Loison I; Pioger A; Paget S; Metatla I; ; Vincent A; Abbadie C; Dehennaut V
    Cell Death Dis; 2024 Oct; 15(10):762. PubMed ID: 39426963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
    Ma Z; Vocadlo DJ; Vosseller K
    J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexosamine biosynthetic pathway and
    Kim DY; Park J; Han IO
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival.
    Fujiwara T; Zhou J; Ye S; Zhao H
    Cell Death Dis; 2016 Jul; 7(7):e2300. PubMed ID: 27441652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
    Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
    J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
    Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
    Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On a sugar high: Role of O-GlcNAcylation in cancer.
    Le Minh G; Esquea EM; Young RG; Huang J; Reginato MJ
    J Biol Chem; 2023 Nov; 299(11):105344. PubMed ID: 37838167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.